These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 28051995

  • 1. In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.
    Hoepfner J, Kleinsorge M, Papp O, Alfken S, Heiringhoff R, Pich A, Sauer V, Zibert A, Göhring G, Schmidt H, Sgodda M, Cantz T.
    Biol Chem; 2017 Jul 26; 398(8):939-954. PubMed ID: 28051995
    [Abstract] [Full Text] [Related]

  • 2. Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells.
    Isono K, Jono H, Ohya Y, Shiraki N, Yamazoe T, Sugasaki A, Era T, Fusaki N, Tasaki M, Ueda M, Shinriki S, Inomata Y, Kume S, Ando Y.
    Stem Cell Res; 2014 Mar 26; 12(2):574-83. PubMed ID: 24531302
    [Abstract] [Full Text] [Related]

  • 3. Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment.
    Suenaga G, Ikeda T, Komohara Y, Takamatsu K, Kakuma T, Tasaki M, Misumi Y, Ueda M, Ito T, Senju S, Ando Y.
    PLoS One; 2016 Mar 26; 11(10):e0163944. PubMed ID: 27695122
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells.
    Niemietz CJ, Sauer V, Stella J, Fleischhauer L, Chandhok G, Guttmann S, Avsar Y, Guo S, Ackermann EJ, Gollob J, Monia BP, Zibert A, Schmidt HH.
    PLoS One; 2016 Mar 26; 11(9):e0161455. PubMed ID: 27584576
    [Abstract] [Full Text] [Related]

  • 5. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
    Sousa MM, Cardoso I, Fernandes R, Guimarães A, Saraiva MJ.
    Am J Pathol; 2001 Dec 26; 159(6):1993-2000. PubMed ID: 11733349
    [Abstract] [Full Text] [Related]

  • 6. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
    Cardoso I, Goldsbury CS, Müller SA, Olivieri V, Wirtz S, Damas AM, Aebi U, Saraiva MJ.
    J Mol Biol; 2002 Apr 12; 317(5):683-95. PubMed ID: 11955017
    [Abstract] [Full Text] [Related]

  • 7. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S.
    Hum Pathol; 2011 Feb 12; 42(2):236-43. PubMed ID: 21056899
    [Abstract] [Full Text] [Related]

  • 8. Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.
    Misumi Y, Ueda M, Obayashi K, Jono H, Su Y, Yamashita T, Ohshima T, Ando Y, Uchino M.
    Hum Pathol; 2012 Jan 12; 43(1):96-104. PubMed ID: 21777941
    [Abstract] [Full Text] [Related]

  • 9. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K, Jono H, Kugimiya-Taguchi T, Nagao S, Su Y, Yamasaki K, Mizuguchi M, Maruyama T, Ando Y, Otagiri M.
    Life Sci; 2013 Dec 18; 93(25-26):1017-22. PubMed ID: 24211615
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    Ando Y.
    Med Mol Morphol; 2005 Sep 18; 38(3):142-54. PubMed ID: 16170462
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
    Murakami T, Yokoyama T, Mizuguchi M, Toné S, Takaku S, Sango K, Nishimura H, Watabe K, Sunada Y.
    J Neurochem; 2021 Mar 18; 156(6):957-966. PubMed ID: 32852783
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Familial amyloidotic polyneuropathy and transthyretin.
    Nagasaka T.
    Subcell Biochem; 2012 Mar 18; 65():565-607. PubMed ID: 23225017
    [Abstract] [Full Text] [Related]

  • 16. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy.
    Tsuchiya-Suzuki A, Yazaki M, Sekijima Y, Kametani F, Ikeda S.
    Amyloid; 2013 Sep 18; 20(3):156-63. PubMed ID: 23826783
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clusterin regulates transthyretin amyloidosis.
    Lee KW, Lee DH, Son H, Kim YS, Park JY, Roh GS, Kim HJ, Kang SS, Cho GJ, Choi WS.
    Biochem Biophys Res Commun; 2009 Oct 16; 388(2):256-60. PubMed ID: 19664600
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation.
    Liu J, Lan J, Zhao P, Zheng F, Song J, Zhang P, Sun X.
    Int J Clin Exp Pathol; 2014 Oct 16; 7(11):7795-800. PubMed ID: 25550818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.